- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Piramal Pharma ropes in 3 new board members
Mumbai: Piramal Pharma Ltd (PPL) on Thursday announced the appointments of Peter Stevenson, Nathalie Leitch and Sridhar Gorthi on its board as part of its plan to bolster business insight and augment organic growth and acquisition strategies.
Stevenson brings in-depth knowledge in contract manufacturing, business operations, supply-chain management and operating in a complex regulatory environment, the company said in a statement.
On the other hand, Gorthi is an authority in corporate law, M&A and private equity. His experience spans across manufacturing, pharmaceuticals, insurance, banking and financial services, technology, telecom and media, it added.
Leitch is a subject matter expert in pharmaceuticals and the US generics industry, with domain experience in creative product strategies and formulations, the company said.
These new appointments come ahead of the planned de-merger of PPL from Piramal Enterprises Ltd (PEL) and will assist the company in maintaining high governance for the new listed corporate entity, the statement said.
The de-merger of PPL was announced in 2021 and upon approval by the National Company Law Tribunal (NCLT), it will be listed on NSE and BSE in India, it added.
Read also: Piramal Pharma Solutions expands API capabilities at Digwal site
PPL is currently led by Chairperson Nandini Piramal and Piramal Global Pharma CEO Peter DeYoung. The company's other board members include industry leaders S Ramadorai, Neeraj Bhardwaj, Jairaj Purandare and Vivek Valsaraj.
Commenting on the appointments, Nandini Piramal said, ''Having a diversified, experienced global board will strengthen our governance, as we vertically de-merge from PEL and become a listed entity.'' She further said, ''The wisdom and knowledge the new members bring will not only enhance the overall expertise of the board, but also provide crucial insights to the businesses, as we scale up our global presence by pursuing both organic and inorganic growth.''
Read also: Herve Berdou appointed as Piramal Pharma Solutions new Chief Operating Officer
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751